Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-24 @ 4:47 PM
NCT ID:
NCT00333450
Eligibility Criteria:
Inclusion:
* healthy children between 11-14 months old who received primary vaccination with Prevnar or GSK Biologicals' pneumococcal conjugate vaccine.
Exclusion:
* children having received or planning to receive any investigational products, vaccines not foreseen in the protocol and immune modifying drugs;
* children having received any additional pneumococcal vaccine than in the primary study;
* children with any disease that affect the immune system and history of seizures and/or allergic disease.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
11 Months
Maximum Age:
14 Months
Study:
NCT00333450
Study Brief:
Protocol Section:
NCT00333450